Connor, Clark & Lunn Investment Management (CC&L)’s Natus Medical Inc NTUS Stock Holding History

Connor, Clark & Lunn Investment Management (CC&L)’s Portfolio NTUS Stock Details NTUS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-10,450	Closed	-$268K	–	1125
2019 Q2	$268K	Buy	+10,450	New	+$266K	﹤0.01%	847
2015 Q1	–	Sell	-35,800	Closed	-$1.29M	–	631
2014 Q4	$1.29M	Buy	35,800 +8,500	+31%	+$286K	0.01%	278
2014 Q3	$806K	Buy	27,300 +3,700	+16%	+$102K	0.01%	336
2014 Q2	$632K	Sell	23,600 -5,900	-20%	-$146K	﹤0.01%	362
2014 Q1	$840K	Buy	29,500 +8,600	+41%	+$217K	0.01%	414
2013 Q4	$500K	Buy	+20,900	New	+$404K	﹤0.01%	494

Other funds holding NTUS

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

SAM

Silvercrest Asset Management New York $13.8B AUM 28.39% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

CRM

Cramer Rosenthal McGlynn Stamford, Connecticut $1.36B AUM 31.72% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return

Connor, Clark & Lunn Investment Management (CC&L)'s NTUS Position: Q3 2019 in Review

Connor, Clark & Lunn Investment Management (CC&L) sold out of Natus Medical Inc (NTUS) in Q3 2019, closing a stake of 10,450 shares — an estimated $268K sold.

Connor, Clark & Lunn Investment Management (CC&L) first reported a position in NTUS in Q4 2013 and held it in 6 quarters. The position peaked at $1.29M in Q4 2014. 168 funds tracked by Wall St. Rank hold NTUS as of Q3 2019.

Connor, Clark & Lunn Investment Management (CC&L) reported no remaining Natus Medical Inc position as of Q3 2019 after selling out during the quarter.
Connor, Clark & Lunn Investment Management (CC&L) sold 10,450 Natus Medical Inc shares in Q3 2019, an estimated $268K.
Connor, Clark & Lunn Investment Management (CC&L) first reported a position in Natus Medical Inc in Q4 2013 and held it in 6 quarters.
Connor, Clark & Lunn Investment Management (CC&L)'s Natus Medical Inc position peaked at $1.29M in Q4 2014.
168 funds tracked by Wall St. Rank held Natus Medical Inc as of Q3 2019.

Based on Connor, Clark & Lunn Investment Management (CC&L)'s 13F filing for Q3 2019, filed 13 Nov 2019.